Chronic cystoid macular oedema treated with intravitreal dobesilate

BMJ Case Reports

Volumn , Issue , 2012, Pages

  Cuevas, Pedro ^a   Outeiriño, Luis A ^b   Angulo, Javier ^a   Giménez Gallego, Guillermo ^c  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b Hospital de Día Pío XII   (Spain)

^c CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2,5 DIHYDROXYBENZENESULFONIC ACID; ETAMSYLATE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CASE REPORT; CATARACT EXTRACTION; DRUG INFORMATION; FEMALE; HUMAN; INTRAOCULAR PRESSURE; OPHTHALMOLOGY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA FOVEA; RETINA MACULA CYSTOID EDEMA; RETINA TUMOR; TREATMENT RESPONSE; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 84865360894     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2012-006376     Document Type: Article

References (17)

1. Aiello LP, Brucker AJ, Chang S, et al. Evolving guidelines for intravitreous injections. Retina 2004;24:S3-19.
2. Quinn CJ. Cystoid macular edema. Optom Clin 1996;5:111-30.
3. Jampol LM, Stephanie MP. Macular edema. In: Ryan S, ed. Retina. 2nd edn. Volume 2. St. Louis, USA: Mosby 1994;61:999-1008.
4. Genead MA, Fishman GA. Cystic macular oedema on spectral-domain optical coherence tomography in choroideremia patients without cystic changes on fundus examination. Eye (Lond). 2011;25:84-90.
5. Sivaprasad S, Bunce C, Crosby-Nwaobi R. Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery. Cochrane Database Syst Rev 2012;2:CD004239.
6. Hariprasad SM, Akduman L, Clever JA, et al. Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%. Clin Ophthalmol 2009;3:147-54.
7. Flach AJ. The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc 1998;96:557-634.
8. Gulkilik G, Kocabora S, Taskapili M, et al. Cystoid macular edema after phacoemulsification: risk factors and effect on visual acuity. Can J Ophthalmol 2006;41:699-703.
9. Heier JS, Topping TM, Baumann W, et al. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema. Ophthalmology 2000;107:2034-8.
10. Choi JY, Buzney SM, Weiter JJ. Cystoid macular edema: current modes of therapy. Int Ophthalmol Clin 2005;45:143-51.
11. Strowig T, Henao-Mejía J, Elinav E, et al. Inflammosomes in health and disease. Nature 2012;481:278-96.
12. Andrés G, Leali D, Mitola S, et al. A pro-inflammatory signatura mediates FGF2-induced angiogenesis. J Cell Mol Med 2009;13:2083-108.
13. Kaga T, Kawano H, Sakaguchi M, et al. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor. Vascul Pharmacol 2012;57:3-9.
14. Fernández IS, Cuevas P, Angulo J, et al. Gentisic acid, a compound associated with plant defence and a metabolite of aspirin, heads a new class of in vivo FGF inhibitor. J Biol Chem 2010;285:1714-29.
15. Angulo J, Peiró C, Romacho T, et al. Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial proliferation, arterial relaxation, vascular permeability and angiogenesis by dobesilate. Eur J Pharmacol 2011;667:153-9.
16. Cuevas P, Outeiriño LA, Angulo J, et al. Treatment of dry age-related macular degeneration with dobesilate. BMJ Case Report 2012;10.1136/bcr.02.2012. 5942, Published 22 June.
17. Haritoglou C, Gerss J, Sauerland C, et al. CALDIRET study group. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRECT study): randomised, double-blind, placebo-controlled, multicentre trial. Lancet 2009;373:1364-71.